Literature DB >> 1732764

Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histochemical investigation.

F G Jennekens1, L F Hesselmans, H Veldman, E N Jansen, F Spaans, P C Molenaar.   

Abstract

A young boy is described who, since early infancy, suffered from weakness of predominantly proximal limb muscles. Electromyography revealed impairment of neuromuscular transmission. There were no antibodies against acetylcholine receptors. The amplitude of miniature end-plate potentials was reduced. Neuromuscular junctions showed somewhat coarse postsynaptic junctional folds and degeneration products in the synaptic clefts and in postsynaptic areas. Using qualitative and semiquantitative histochemical methods, at light- and electronmicroscopical levels, acetylcholinesterase (AChE) activity and acetylcholine receptors (AChRs) were demonstrated to be deficient. This patient demonstrates that the clinical picture of congenital myasthenia may closely resemble a congenital myopathy. The findings provide evidence that AChR deficiency offers protection from some of the effects of AChE deficiency. The clinical features of AChE deficiency depend, not only on the level of residual enzyme activity, but also on the degree of AChR reduction, if present.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732764     DOI: 10.1002/mus.880150112

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

Review 1.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

2.  Congenital oculo-bulbar palsy.

Authors:  F G Jennekens; H Veldman; L J Vroegindeweij-Claessens; P C Molenaar; A A Op de Coul
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

3.  Transgenic engineering of neuromuscular junctions in Xenopus laevis embryos transiently overexpressing key cholinergic proteins.

Authors:  M Shapira; S Seidman; M Sternfeld; R Timberg; D Kaufer; J Patrick; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

4.  Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits.

Authors:  S Camp; S Bon; Y Li; D K Getman; A G Engel; J Massoulié; P Taylor
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).

Authors:  C Donger; E Krejci; A P Serradell; B Eymard; S Bon; S Nicole; D Chateau; F Gary; M Fardeau; J Massoulié; P Guicheney
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

6.  Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys.

Authors:  Mario Losen; Aran F Labrijn; Vivianne H van Kranen-Mastenbroek; Maarten L Janmaat; Krista G Haanstra; Frank J Beurskens; Tom Vink; Margreet Jonker; Bert A 't Hart; Marina Mané-Damas; Peter C Molenaar; Pilar Martinez-Martinez; Eline van der Esch; Janine Schuurman; Marc H de Baets; Paul W H I Parren
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.